OM
Opaleye Management Portfolio holdings
AUM
$494M
This Quarter Return
+20.47%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.29%
AUM
$239M
AUM Growth
+$239M
(+18%)
Cap. Flow
+$7.57M
Cap. Flow
% of AUM
3.16%
Top 10 Holdings %
Top 10 Hldgs %
37.89%
Holding
60
New
11
Increased
16
Reduced
16
Closed
7
Top Buys
| 1 |
RLYP
RELYPSA INC COM
RLYP
|
$6.24M |
| 2 |
Assertio
ASRT
|
$5.44M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$4.66M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$3.82M |
| 5 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$3.78M |
Top Sells
| 1 |
CMRX
Chimerix, Inc.
CMRX
|
$11.8M |
| 2 |
ZSPH
ZS PHARMA INC COMS TK (DE)
ZSPH
|
$6.24M |
| 3 |
CEMP
Cempra, Inc.
CEMP
|
$4.98M |
| 4 |
Neurocrine Biosciences
NBIX
|
$3.96M |
| 5 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$2.63M |
Sector Composition
| 1 | Healthcare | 79.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ultragenyx Pharmaceutical
RARE
$2.89B
| $12.3M | 5.16% | 110,000 | – | – |
|
2
Axogen
AXGN
$743M
| $10.6M | 4.43% | 2,120,000 | – | – |
|
3
FibroGen
FGEN
$47.8M
| $9.9M | 4.14% | 325,000 | – | – |
|
4
Geron
GERN
$893M
| $8.83M | 3.69% | 1,825,000 | – | – |
|
|
GNMX
5
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
| $8.37M | 3.5% | 1,390,000 +331,600 | +31% | +$2M |
|
6
Harrow
HROW
$1.44B
| $8.35M | 3.49% | 1,205,000 | – | – |
|
|
ISEE
7
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $8.25M | 3.45% | 105,000 | – | – |
|
|
ARIA
8
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $8.19M | 3.42% | 1,310,000 | – | – |
|
|
EGRX
9
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $7.54M | 3.15% | 85,000 +11,800 | +16% | +$1.05M |
|
|
BPMC
10
DELISTED
Blueprint Medicines
BPMC
| $7.24M | 3.03% | 275,000 +145,000 | +112% | +$3.82M |
|
|
TVRD
11
Tvardi Therapeutics, Inc. Common Stock
TVRD
$281M
| $7.2M | 3.01% | 427,000 +12,000 | +3% | +$202K |
|
12
Codexis
CDXS
$246M
| $6.77M | 2.83% | 1,600,000 -20,000 | -1% | -$84.6K |
|
13
Travere Therapeutics
TVTX
$1.56B
| $6.66M | 2.78% | 345,000 -25,000 | -7% | -$482K |
|
|
RLYP
14
DELISTED
RELYPSA INC COM
RLYP
| $6.24M | 2.61% | +220,000 | New | +$6.24M |
|
|
CEMP
15
DELISTED
Cempra, Inc.
CEMP
| $6.23M | 2.6% | 200,000 -160,000 | -44% | -$4.98M |
|
|
SAGE
16
DELISTED
Sage Therapeutics
SAGE
| $5.83M | 2.44% | 100,000 +80,000 | +400% | +$4.66M |
|
17
Supernus Pharmaceuticals
SUPN
$2.53B
| $5.65M | 2.36% | 420,000 -40,000 | -9% | -$538K |
|
|
18
Assertio
ASRT
$80.4M
| $5.44M | 2.27% | +300,000 | New | +$5.44M |
|
|
ADMS
19
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $5.38M | 2.25% | 190,000 +24,300 | +15% | +$688K |
|
|
AMAG
20
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $4.53M | 1.89% | 150,000 -50,000 | -25% | -$1.51M |
|
21
Tonix Pharmaceuticals
TNXP
$260M
| $4.33M | 1.81% | 565,000 -5,000 | -0.9% | -$38.4K |
|
|
AVGR
22
DELISTED
Avinger, Inc. Common Stock
AVGR
| $4.32M | 1.8% | 190,000 +15,000 | +9% | +$341K |
|
|
AFMD
23
DELISTED
Affimed
AFMD
| $4.24M | 1.77% | 595,000 +4,700 | +0.8% | +$33.5K |
|
|
FOMX
24
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $4.06M | 1.7% | 500,000 +215,000 | +75% | +$1.74M |
|
|
LJPC
25
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $3.78M | 1.58% | +140,000 | New | +$3.78M |
|